Pharmafile Logo
Pharmafocus logo
Advanced Search

Trial paused for respiratory virus vaccine in pregnant women

February 18, 2022
Medical Communications

GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …

News

FDA accepts NDA for non-small cell lung cancer treatment

February 17, 2022
Business Services

Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …

News

England to offer COVID-19 vaccine to five to 11-year-olds

February 17, 2022
Business Services

Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …

News

First Promising Innovative Medicine designation for self-administered treatment of rare disease

February 17, 2022
Business Services

UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …

News

Virtual drug design platform to accelerate drug discovery

February 17, 2022
Business Services

The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …

News

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022
Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …

News

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022
Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …

News

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022
Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …

News

Moderna launch Omicron-specific UK vaccine study

February 16, 2022
Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …

News

Astellas and Seagen announce results of study into muscle-invasive bladder cancer

February 15, 2022
Medical Communications

Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …

News

Genuv partners with Aiforia for AI-Powered Drug Screening Platform

February 15, 2022
Manufacturing and Production

Genuv has announced an agreement with the medical technology company Aiforia Technologies, to add Aiforia’s AI deep learning for medical …

News

NICE recommends new diagnostic devices for men with suspected prostate cancer

February 15, 2022
Medical Communications

NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …

News

‘Game-changing’ South African mRNA hub set to be a foundation for self-reliance

February 15, 2022
Manufacturing and Production

WHO officials have visited a number of public and private sector partners that are collaborating to develop and build WHO’s …

News

FDA approves Eversense CGM system for use for up to six months

February 14, 2022
Sales and Marketing

The FDA has approved Senseonics’ Eversense E3 CGM System, which includes proprietary sacrificial boronic acid (SBA) technology to extent longevity …

News

AbbVie submits applications for treatment of chronic disease

February 14, 2022
Sales and Marketing

AbbVie has announced the submission of applications seeking the approval of upadacitinib, (RINVOQ®, 15 mg once daily) for the treatment …

News

Gilead’s HIV treatment demonstrates high efficacy and viral suppression at five years

February 14, 2022
Sales and Marketing

Gilead Sciences has announced the presentation of cumulative five-year results from two Phase III studies of Biktarvy. The new, long-term …

News

First UK Lassa fever death in over a decade

February 14, 2022
Sales and Marketing

A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …

News

Risk of new heart problems raised after COVID-19

February 11, 2022
Medical Communications

A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …

News

Novavax COVID-19 vaccine meets trial endpoints

February 11, 2022
Medical Communications

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, achieved its primary effectiveness endpoint in the paediatric expansion …

News

Sickest patients face record long waits for hospital bed

February 11, 2022
Medical Communications

According to NHS data, the sickest patients are facing record long waits for a bed upon admission to hospital in …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025